Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA ® Observational Database-Reference-Cited by-同舟云学术

Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA ® Observational Database

Published:2019-12 Issue:12 Volume:22 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Pierone Gerald¹^ORCID,Henegar Cassidy²^ORCID,Fusco Jennifer³^ORCID,Vannappagari Vani²^ORCID,Aboud Michael⁴^ORCID,Ragone Leigh²^ORCID,Fusco Gregory³^ORCID

Affiliation:

1. Whole Family Health Center Vero Beach FL USA

2. ViiV Healthcare Research Triangle Park NC USA

3. Epividian, Inc Durham NC USA

4. ViiV Healthcare London United Kingdom

Funder

ViiV Healthcare

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25418

Reference33 articles.

1. Tenofovir and bone health

2. Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence

3. Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review

4. Panel on Antiretroviral Guidelines for Adults and Adolescent.Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV Department of Health and Human Services.2018[cited 2018 Aug 14]. Available from:https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

5. Simplification strategies to reduce antiretroviral drug exposure: progress and prospects;McKinnon JE;Antivir Ther,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain;FARM HOSP;2022

2. Characteristics of 2-drug regimen users living with HIV-1 in a real-world setting: A large-scale medical claim database analysis in Japan;PLOS ONE;2022-06-14

3. Short Communication:Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort;AIDS Research and Human Retroviruses;2022-06-01

4. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort;Infectious Diseases and Therapy;2022-04-11

5. Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV;International Journal of Antimicrobial Agents;2021-09